AEN-100

Adeona is currently preparing for a clinical trial of patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease. Preparations are underway to evaluate the safety and efficacy of the proprietary drug candidate, AEN-100, a once-daily, gastroretentive, sustained-release oral tablet formulation of zinc acetate.